140 related articles for article (PubMed ID: 17956908)
1. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus.
McGuigan C; Pathirana RN; Migliore M; Adak R; Luoni G; Jones AT; Díez-Torrubia A; Camarasa MJ; Velázquez S; Henson G; Verbeken E; Sienaert R; Naesens L; Snoeck R; Andrei G; Balzarini J
J Antimicrob Chemother; 2007 Dec; 60(6):1316-30. PubMed ID: 17956908
[TBL] [Abstract][Full Text] [Related]
2. FV-100: the most potent and selective anti-varicella zoster virus agent reported to date.
Migliore M
Antivir Chem Chemother; 2010 Jan; 20(3):107-15. PubMed ID: 20054098
[TBL] [Abstract][Full Text] [Related]
3. Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication.
Balzarini J; McGuigan C
J Antimicrob Chemother; 2002 Jul; 50(1):5-9. PubMed ID: 12096000
[TBL] [Abstract][Full Text] [Related]
4. 2'-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743.
McGuigan C; Derudas M; Quintiliani M; Andrei G; Snoeck R; Henson G; Balzarini J
Bioorg Med Chem Lett; 2009 Nov; 19(22):6264-7. PubMed ID: 19833513
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
Balzarini J; McGuigan C
Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470
[TBL] [Abstract][Full Text] [Related]
6. Bicyclic nucleoside inhibitors of varicella-zoster virus: 5'-chloro and 3'-chloro derivatives.
Luoni G; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):931-3. PubMed ID: 14565314
[TBL] [Abstract][Full Text] [Related]
7. Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues.
De Clercq E
Med Res Rev; 2003 May; 23(3):253-74. PubMed ID: 12647310
[TBL] [Abstract][Full Text] [Related]
8. FV100 as a new approach for the possible treatment of varicella-zoster virus infection.
McGuigan C; Balzarini J
J Antimicrob Chemother; 2009 Oct; 64(4):671-3. PubMed ID: 19679595
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and pharmacological characteristics of the bicyclic nucleoside analogues (BCNAs) as highly selective inhibitors of varicella-zoster virus (VZV).
Sienaert R; Naesens L; Brancale A; Carangio A; Andrei G; Snoeck R; Van Kuilenburg A; De Clercq E; McGuigan C; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):995-7. PubMed ID: 14565329
[No Abstract] [Full Text] [Related]
10. Synthesis of unusual bicyclic nucleosides bearing an unsaturated side-chain, as potential inhibitors of varicella-zoster virus (VZV).
Bidet O; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):817-9. PubMed ID: 14565286
[No Abstract] [Full Text] [Related]
11. Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase.
Sienaert R; Andrei G; Snoeck R; De Clercq E; McGuigan C; Balzarini J
Biochem Biophys Res Commun; 2004 Mar; 315(4):877-83. PubMed ID: 14985094
[TBL] [Abstract][Full Text] [Related]
12. Bicyclic nucleoside inhibitors of varicella-zoster virus modified on the sugar moiety: 3' and 5' derivatives.
Luoni GM; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2004 Nov; 15(6):333-41. PubMed ID: 15646647
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.
Andrei G; Sienaert R; McGuigan C; De Clercq E; Balzarini J; Snoeck R
Antimicrob Agents Chemother; 2005 Mar; 49(3):1081-6. PubMed ID: 15728906
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of novel phosphoramidate ProTides of the 2'-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue.
Derudas M; Quintiliani M; Brancale A; Andrei G; Snoeck R; Balzarini J; McGuigan C
Antivir Chem Chemother; 2010 Oct; 21(1):15-31. PubMed ID: 21045257
[TBL] [Abstract][Full Text] [Related]
15. FV-100 for the Treatment of Varicella-Virus (VZV) Infections: Quo Vadis?
De Clercq E
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458500
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase IV-activated prodrugs of anti-varicella zoster virus bicyclic nucleoside analogues containing different self-cleavage spacer systems.
Diez-Torrubia A; Cabrera S; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
ChemMedChem; 2012 Sep; 7(9):1612-22. PubMed ID: 22887971
[TBL] [Abstract][Full Text] [Related]
17. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
[TBL] [Abstract][Full Text] [Related]
18. Furano pyrimidines as novel potent and selective anti-VZV agents.
McGuigan C; Brancale A; Barucki H; Srinivasan S; Jones G; Pathirana R; Carangio A; Blewett S; Luoni G; Bidet O; Jukes A; Jarvis C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2001 Mar; 12(2):77-89. PubMed ID: 11527045
[TBL] [Abstract][Full Text] [Related]
19. Bicyclic nucleoside inhibitors of varicella-zoster virus: effect of terminal aryl substitution in the side-chain.
Carangio A; Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2002 Sep; 13(5):263-71. PubMed ID: 12630674
[TBL] [Abstract][Full Text] [Related]
20. Bicyclic anti-VZV nucleosides: thieno analogues bearing an alkylphenyl side chain have reduced antiviral activity.
Angell A; McGuigan C; Garcia Sevillano L; Snoeck R; Andrei G; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2004 May; 14(10):2397-9. PubMed ID: 15109620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
